Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2026-05-29 @ 4:29 AM
Study NCT ID:
NCT00323804
Status:
COMPLETED
Last Update Posted:
2014-09-04
First Post:
2006-05-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Sponsor:
ANRS, Emerging Infectious Diseases
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
ANRS HC15 NRfi
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None